Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil J Stone

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
European Heart Journal|January 16, 2023
RACING to judgement: weighing the value of pre-specified subgroup analysesNeil J Stone
JAMA Cardiology|November 15, 2021
Treating Severe Hypercholesterolemia-If Not Now, When?Neil J Stone
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Focus on lifestyle change and the metabolic syndromeNeil J Stone
Managed Care (Langhorne, Pa.)|October 9, 2002
Current drug treatments for lipid managementNeil J Stone
Trends in Cardiovascular Medicine|November 7, 2019
Editorial commentary: Risk factors, enhancing factors and ASCVD in inflammatory bowel diseasesNeil J Stone
Trends in Cardiovascular Medicine|December 4, 2015
MY APPROACH to cardiovascular risk assessment to reduce atherosclerotic riskNeil J Stone
Current Atherosclerosis Reports|October 22, 2008
The long-term effect of lifestyle interventions to prevent diabetesNeil J Stone
The American Journal of Cardiology|December 17, 2008
Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidenceNeil J Stone
JAMA Cardiology|March 15, 2017
Factors Affecting the Cost of Airplanes and Use of Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorsNeil J Stone
Journal of the American Heart Association|August 21, 2016
Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats RemainNeil J Stone
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
European Heart Journal|January 16, 2023
RACING to judgement: weighing the value of pre-specified subgroup analysesNeil J Stone
JAMA Cardiology|November 15, 2021
Treating Severe Hypercholesterolemia-If Not Now, When?Neil J Stone
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Focus on lifestyle change and the metabolic syndromeNeil J Stone
Managed Care (Langhorne, Pa.)|October 9, 2002
Current drug treatments for lipid managementNeil J Stone
Trends in Cardiovascular Medicine|November 7, 2019
Editorial commentary: Risk factors, enhancing factors and ASCVD in inflammatory bowel diseasesNeil J Stone
Trends in Cardiovascular Medicine|December 4, 2015
MY APPROACH to cardiovascular risk assessment to reduce atherosclerotic riskNeil J Stone
Current Atherosclerosis Reports|October 22, 2008
The long-term effect of lifestyle interventions to prevent diabetesNeil J Stone
The American Journal of Cardiology|December 17, 2008
Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidenceNeil J Stone
JAMA Cardiology|March 15, 2017
Factors Affecting the Cost of Airplanes and Use of Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorsNeil J Stone
Journal of the American Heart Association|August 21, 2016
Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats RemainNeil J Stone
Pageof 21